ClinicalTrials.Veeva

Menu

Biomarker-s of Abusive Head Trauma by Proteomics

University Hospitals (UH) logo

University Hospitals (UH)

Status

Not yet enrolling

Conditions

Protein Disorder, Blood
Abuse, Child

Treatments

Other: Blood test

Study type

Observational

Funder types

Other

Identifiers

NCT05626465
2021-01971

Details and patient eligibility

About

The aim of our study is to highlight biomarker-s of Abusive Head Trauma by proteomics analyses on the serum of child victims of abuse.

Enrollment

174 estimated patients

Sex

All

Ages

Under 2 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age : 0-2 y.o
  • Medical consultation for malaise, seizure (without fever), loss of consciousness, traumatic bain injury, or cranioplasty
  • Blood test during medical care
  • Accepted informed consent

Exclusion criteria

  • Refused informed consent
  • For control groups : medical history of child abuse
  • For AHT group : rare metabolic disease (Menkes, etc..)

Trial design

174 participants in 4 patient groups

Abusive Head Trauma (AHT)
Treatment:
Other: Blood test
Accidental traumatic brain injury
Treatment:
Other: Blood test
Cranioplasty
Treatment:
Other: Blood test
Infant malaise without AHT
Treatment:
Other: Blood test

Trial contacts and locations

2

Loading...

Central trial contact

Kim Wiskott, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems